Mark Foley

Mark Foley

Managing Director

RWI Ventures


Since joining RWI Ventures in 2004, Mark has led the firm’s healthcare investments. Representative investments where Mark led the financing and joined the Board of Directors include BaroSense (where he was the lead Series B investor), Sonitus Medical (where he was the sole Series A investor) and Voyage Medical (where he was also the sole Series A investor).
Co-investors investing in the same or later rounds of Mark’s portfolio companies include: Kleiner Perkins, Three Arch Partners, Novartis, Aberdare Ventures, Delphi Ventures, Frazier Healthcare, Abbott, Foundation Capital, Bessemer Venture Partners, along with others.

Additionally, Mark serves as Executive Chairman/Board Member for Zeltiq Aesthetics and Onpharma (formerly Monterey Devices).

Prior to RWI Ventures, Mark spent 17 years in senior operating roles at both large and small start-up medical device companies, most recently founding and serving as CEO of cardiac device maker, Ventrica, which was acquired by Medtronic in 2004. Before Ventrica, Mark worked for leading device companies Perclose (acquired by Abbott), Guidant, DVI (acquired by Eli Lilly), US Surgical Corporation (acquired by Tyco) and American Cyanamid.

Because of the breadth of his operating experience, Mark has an intimate understanding of all aspects of what it takes to make a start-up company successful, as well as an extensive rolodex and strong personal relationships with many key influencers in the Bay Area.

Mark received his B.A. from the University of Notre Dame and is a named inventor on 13 patents.